PULMONX CORPORATION - COMMON STOCK

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

20 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

07 Nov 2024 16:05:01 By Nasdaq GlobeNewswire

Pulmonx to Present at the Stifel 2024 Healthcare Conference

05 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx Reports Third Quarter 2024 Financial Results

30 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

16 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

09 Sep 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

29 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

22 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx Reports Second Quarter 2024 Financial Results

31 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

29 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

10 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 May 2024 17:03:06 By Nasdaq GlobeNewswire

Pulmonx Reports First Quarter 2024 Financial Results

01 May 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

10 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

02 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

15 Mar 2024 17:00:37 By Nasdaq GlobeNewswire

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

21 Feb 2024 16:06:00 By Nasdaq GlobeNewswire

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

21 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

07 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

15 Nov 2023 16:05:00 By Nasdaq GlobeNewswire